Silent hereditary hematochromatosis as a susceptibility factor of doxorubicin-induced acute cardiac failure

Ann Oncol. 2010 Nov;21(11):2293-2294. doi: 10.1093/annonc/mdq567. Epub 2010 Oct 11.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Doxorubicin / adverse effects*
  • Fatal Outcome
  • Genetic Predisposition to Disease*
  • Heart Failure / etiology*
  • Hemochromatosis / genetics*
  • Humans
  • Leiomyosarcoma / drug therapy*
  • Leiomyosarcoma / secondary
  • Male

Substances

  • Doxorubicin